Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Iovance Biotherapeutics, Inc.

NASDAQ: IOVA · Life Sciences · 7 alerts · CIK 1425205

Share price
$7.55Close, Nov 16
Market cap
$3.49B
Shares outstanding
462.66MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Iovance Biotherapeutics, Inc. filings on SEC EDGAR ↗

7:06 AM ET 8-K
Investor Meeting

Iovance Biotherapeutics Investor Meeting

Iovance Biotherapeutics raised its full-year 2026 total revenue guidance to a range of $410 million to $420 million, up from the previous range of $350 million to $370 million. The increase is driven by strong U.S. demand for its cancer therapies Amtagvi and Proleukin, representing approximately 60% annual growth.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.